Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Role of dopamine in the pathophysiology of Parkinson’s disease
Zhidong Zhou, Ling Yi, Qing Wang, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 75
Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
Sasanka Chakrabarti, Marco Bisaglia
Antioxidants (2023) Vol. 12, Iss. 4, pp. 955-955
Open Access | Times Cited: 49
Current trends in basic research on Parkinson’s disease: from mitochondria, lysosome to α-synuclein
Hideaki Matsui, Ryōsuke Takahashi
Journal of Neural Transmission (2024) Vol. 131, Iss. 6, pp. 663-674
Open Access | Times Cited: 8
Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases
David S. Goldstein, Courtney Holmes, Patti Sullivan, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 1
Open Access | Times Cited: 20
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model
Sandro Huenchuguala, Juan Segura‐Aguilar
Biomolecules (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
A SPLICS reporter reveals $${{{{{\boldsymbol{\alpha }}}}}}$$-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation
Flavia Giamogante, Lucia Barazzuol, Francesca Maiorca, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson’s Disease
Ling Yi, Eng King Tan, Zhidong Zhou
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4643-4643
Open Access | Times Cited: 5
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model
Natalia López‐González del Rey, Nagore Hernández-Pinedo, Maria Christina Carrillo, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Reversing Signs of Parkinsonism in a Cell Model Using Mitochondria-Targeted Organoiridium Catalysis
Rahul D. Jana, Hieu D. Nguyen, Guangjie Yan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
Felipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Revisiting the advance of age-dependent α-synuclein propagation and aggregation
Dong‐Yan Song, Jiayi Li
Ageing and Neurodegenerative Diseases (2025) Vol. 5, Iss. 1
Open Access
MicroRNAs alteration and unique distribution in the soma and synapses of substantia nigra in Parkinsons disease
Morgan N. Ogwo, Gunjan Goyal, Peter Zotor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
SARS-CoV-2-Mimicking Pseudoviral Particles Accelerate α-Synuclein Aggregation In Vitro
Gianluca Zilio, Anna Masato, Michele Sandre, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 2, pp. 215-221
Closed Access | Times Cited: 6
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Javiera Arcos, Felipe Grünenwald, Denisse Sepúlveda, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis
Anna Masato, Annapaola Andolfo, Giulia Favetta, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 1
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, et al.
NeuroToxicology (2024) Vol. 103, pp. 266-287
Closed Access | Times Cited: 1
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease
Sandro Huenchuguala, Juan Segura‐Aguilar
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1125-1125
Open Access | Times Cited: 1
Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules
Antonino Natalello, Stefania Brocca, Erika Ponzini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 2
Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures
Enrico Bagnoli, Alexandre Trotier, Jill McMahon, et al.
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 2
Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease
Sora Kang, Youngjin Noh, Seung Jun Oh, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 7988-7988
Open Access | Times Cited: 2
Photooxidation of Genetically Encoded MiniSOG-Fused VGLUT2 for Identification of Glutamatergic Synapses by Transmission and 3D Electron Microscopy
Andrew J. Flores, Anna Nilsson, Junru Hu, et al.
Neuromethods (2024), pp. 135-151
Closed Access
Mitochondrial Dysfunction in Parkinson’s Disease: A Contribution to Cognitive Impairment?
Antonella Scorziello, Rossana Sirabella, Maria Josè Sisalli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11490-11490
Open Access
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in The Rat Rotenone Model: Relevance to The Catecholaldehyde Hypothesis for The Pathogenesis of Parkinson’s Disease
Rawan Khashab, Naama Gutman-Sharabi, Zehava Shabtai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12522-12522
Open Access | Times Cited: 1
Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson’s Disease Pathogenesis
Xuanxiang Jin, Xiaoli Si, Xiaoguang Lei, et al.
Aging and Disease (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top